276 related articles for article (PubMed ID: 15522758)
1. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
Gupta AK; Gupta M
Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
[TBL] [Abstract][Full Text] [Related]
2. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
Gupta AK; Curtis AS
Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.
Petri-Fink A; Steitz B; Finka A; Salaklang J; Hofmann H
Eur J Pharm Biopharm; 2008 Jan; 68(1):129-37. PubMed ID: 17881203
[TBL] [Abstract][Full Text] [Related]
5. In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles.
Gaihre B; Hee Lee Y; Khil MS; Yi HK; Kim HY
J Microencapsul; 2011; 28(4):240-7. PubMed ID: 21545315
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system.
Gupta M; Gupta AK
J Pharm Pharm Sci; 2004 Feb; 7(1):38-46. PubMed ID: 15144733
[TBL] [Abstract][Full Text] [Related]
7. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
Ma HL; Qi XR; Ding WX; Maitani Y; Nagai T
J Biomed Mater Res A; 2008 Mar; 84(3):598-606. PubMed ID: 17618488
[TBL] [Abstract][Full Text] [Related]
8. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier.
Gupta M; Gupta AK
J Control Release; 2004 Sep; 99(1):157-66. PubMed ID: 15342188
[TBL] [Abstract][Full Text] [Related]
9. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
10. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
11. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture.
Gupta AK; Curtis AS
J Mater Sci Mater Med; 2004 Apr; 15(4):493-6. PubMed ID: 15332623
[TBL] [Abstract][Full Text] [Related]
12. Cell toxicity of superparamagnetic iron oxide nanoparticles.
Mahmoudi M; Simchi A; Milani AS; Stroeve P
J Colloid Interface Sci; 2009 Aug; 336(2):510-8. PubMed ID: 19476952
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
Gupta AK; Berry C; Gupta M; Curtis A
IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
16. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
17. Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state.
Safi M; Sarrouj H; Sandre O; Mignet N; Berret JF
Nanotechnology; 2010 Apr; 21(14):145103. PubMed ID: 20234082
[TBL] [Abstract][Full Text] [Related]
18. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.
Huang X; Teng X; Chen D; Tang F; He J
Biomaterials; 2010 Jan; 31(3):438-48. PubMed ID: 19800115
[TBL] [Abstract][Full Text] [Related]
19. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
Steitz B; Salaklang J; Finka A; O'Neil C; Hofmann H; Petri-Fink A
Bioconjug Chem; 2007; 18(5):1684-90. PubMed ID: 17718533
[TBL] [Abstract][Full Text] [Related]
20. The influence of polycaprolactone coating on the internalization and cytotoxicity of gold nanoparticles.
Mao Z; Wang B; Ma L; Gao C; Shen J
Nanomedicine; 2007 Sep; 3(3):215-23. PubMed ID: 17706466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
